2012

 TitoloAutoriRivistaIF 2012IF 2014
60A MULTICENTER PHASE III PROSPECTIVE RANDOMIZED TRIAL OF HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE (EC) VERSUS DOCETAXEL FOLLOWED BY EC IN NODE-POSITIVE BREAST CANCER. GOIM (GRUPPO ONCOLOGICO ITALIA MERIDIONALE) 9902 STUDYP. Vici, M. Brandi, F. Giotta, P. Foggi, F. Schittulli, L. Di Lauro, N. Gebbia, B. Massidda, G. Filippelli, D. Giannarelli, A. Di Benedetto, M. Mottolese, G. Colucci, M. Lopez:Ann Oncol. 2012; 5:1121-97.3847.04
61THE EMERGING ROLE OF ALK INHIBITORS IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCERGaletta D, Rossi A, Pisconti S, Colucci G. :Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S45-544.135.139